Trial Profile
fMRI and neurophysiological study protocol on cannabinoids in multiple sclerosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 29 Oct 2005 New trial record.